Physician profile
Robert Yant
NPI 1700840667
$1,267.36
in general payments reported to CMS, 2019-2025
15 companies · $14.34 in 2025
The $14.34 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $170 · 2021: $182 · 2022: $226 · 2023: $74.21 · 2024: $33.52 · 2025: $14.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $735.32 | 2019-2022 | |
| Stryker Corporation | $216.93 | 2019 | |
| Zyla Life Sciences, INC. | $48.89 | 2019 | |
| Melinta Therapeutics, LLC | $43.40 | 2019 | |
| Bard Peripheral Vascular, INC. | $42.32 | 2021 | |
| Djo, LLC | $25.53 | 2022 | |
| Access Pro Medical, LLC | $24.92 | 2023 | Matriderm |
| Progenacare Global, LLC | $18.50 | 2023 | |
| Smith+Nephew, INC. | $18.17 | 2023 | Collagenase Santyl |
| Bioventus LLC | $17.32 | 2024 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $17.16 | 2022 | |
| Medtronic, INC. | $16.20 | 2024 | Venaseal |
| Triad Life Sciences INC. | $15.74 | 2022 | |
| Innovation Technologies INC | $14.34 | 2025 | Irrisept |
| Advanced Oxygen Therapy INC. | $12.62 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Yant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.